In addition to its localization and physiological function, HLA-G expression has been observed in different types of tumors, such as gastric (60), colorectal (61) and breast (62) cancer, among others, where it favors tumor progression by inhibiting the immune system surveillance (63). Here, HLA-G is linked to neoplasm.